Cimatron Reports Non-GAAP Net Profit of $1 Million in the Fourth Quarter of 2009

Cimatron Limited (NASDAQ: CIMT) ("Cimatron" or the "Company"), a leading provider of integrated CAD/CAM solutions for the toolmaking and manufacturing industries, today announced financial results for the fourth quarter and full year 2009.

The following provides details on Cimatron's GAAP and non-GAAP results for the fourth quarter and full year 2009:

GAAP:
Revenues for the fourth quarter of 2009 were $9.8 million, compared to $10.4 million recorded in the fourth quarter of 2008. In the full year ended December 31, 2009, revenues were $33 million, compared to $41 million in 2008.

Gross Profit for the fourth quarter of 2009 was $8 million as compared to $8.3 million for the same period in 2008. Gross margin in the fourth quarter of 2009 was 82% of revenues, compared to a gross margin of 79% in the fourth quarter of 2008. In 2009, gross profit was $26.8 million, compared to $33.2 million in 2008. Gross margin in 2009 constituted 81% of revenues, reflecting no change relative to 2008.

Operating Profit in the fourth quarter of 2009 was $773 thousand, compared to an operating profit of $652 thousand in the fourth quarter of 2008. In 2009, Cimatron recorded an operating loss of $(957) thousand, compared to an operating profit of $526 thousand in 2008.

Net Profit for the fourth quarter of 2009 was $1.4 million, or $0.15 per diluted share, compared to a net profit of $706 thousand, or $0.08 per diluted share recorded for the same quarter of 2008.

In 2009, net profit was $14 thousand, or $0.00 per diluted share, compared to a net profit of $724 thousand, or $0.08 per diluted share, in 2008.

Non-GAAP:

Revenues on a non-GAAP basis for the fourth quarter of 2009 were $9.8 million, compared to $10.5 million recorded for the fourth quarter of 2008. In the full year ended December 31, 2009, revenues were $33 million, compared to $41.8 million in 2008.

Gross Profit on a non-GAAP basis for the fourth quarter of 2009 was $8.2 million as compared to $8.5 million for the same period in 2008. Gross margin in the fourth quarter of 2009 was 84% of revenues, compared to 81% in the fourth quarter of 2008. In 2009, gross profit on a non-GAAP basis was $27.4 million, compared to $34.6 million in 2008. Gross margin on a non-GAAP basis in 2009 constituted 83% of revenues, reflecting no change relative to 2008.

Operating Profit on a non-GAAP basis in the fourth quarter of 2009 was $1 million, compared to an operating profit of $977 thousand in the fourth quarter of 2008. In 2009, Cimatron recorded an operating profit of $31 thousand, compared to operating profit of $2.3 million in 2008.

Net Profit on a non-GAAP basis for the fourth quarter of 2009 was $955 thousand, or $0.10 per diluted share, compared to net profit of $553 thousand, or $0.06 per diluted share recorded in the same quarter of 2008. In 2009, net profit was $46 thousand, or $0.01 per diluted share, compared to net profit of $2.2 million, or $0.23 per diluted share, in 2008.

Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, said "We are very pleased with the fourth quarter results. The combination of higher revenues (relative to previous quarters in 2009) and continued tight budget control has resulted in a strong bottom line in the fourth quarter, and positive cash flow for the entire year. 2009 was one of the toughest years for our industry, ever. In spite of a steep drop in global demand, we were able to generate a significant amount of cash in 2009, and even show small non-GAAP operating and net profits for the year. We are confident that our strong market position, strong balance sheet, and healthy cash reserves, together with continued investment in marketing and product development, will help us take advantage of new business opportunities. We are witnessing some signs of market recovery, and look forward to a hopefully less turbulent 2010", concluded Mr. Haran.

Conference Call

Cimatron's management will host a conference call tomorrow, February 23rd, 2010 at 9:00 EST, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.

To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.

                              USA: +1-800-994-4498
                          International: +972-3-9180644
                               Israel: 03-9180644

For those unable to listen to the live call, a replay of the call will be available from the day after the call at the investor relations section of Cimatron's website, at: http://www.cimatron.com

Reconciliation between results on a GAAP and Non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-GAAP charges and other items that are considered by management to be outside our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance, especially as our two most recent acquisitions have resulted in amortization and non-cash items that have had a material impact on our GAAP results. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.

About Cimatron

With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers, as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com.

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act Of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the Company's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties of the business, refer to the Company's filings with the Securities and Exchanges Commission. The Company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

                               CIMATRON LIMITED
                       CONSOLIDATED STATEMENTS OF INCOME
             (US Dollars in thousands, except for per share data)

                                 Three months ended      Twelve months ended
                                     December 31,            December 31,
                                  2009        2008        2009        2008

    Total revenue                9,762      10,404      32,957      40,975

    Total cost of revenue        1,719       2,142       6,186       7,769

    Gross profit                 8,043       8,262      26,771      33,206

    Research and development
    expenses, net                1,347       1,657       5,736       6,930

    Selling, general and
    administrative expenses      5,923       5,953      21,992      25,750

    Operating income (loss)        773         652        (957)        526

    Financial income
    (expenses), net.                38        (207)         19         (80)

    Taxes on Income                639         263         949         237

    Other                          (41)          5         (41)          -

    Net income (loss)            1,409         713         (30)        683

    Less: Net loss (gain)
    attributable to the
    noncontrolling interest        (18)      (*)(7)         44       (*)41

    Net income attributable to
    Cimatron's shareholders    $ 1,391       $ 706        $ 14       $ 724

    Net income per share -
    basic and diluted           $ 0.15      $ 0.08      $ 0.00      $ 0.08

    Weighted average number of
    shares outstanding

              Basic EPS
              (in thousands)     9,128       9,274       9,156       9,341

              Diluted EPS
              (in thousands)     9,128       9,274       9,156       9,360

              (*) Reclassification due to the adoption of SFAS 160






                                    CIMATRON LIMITED
                  RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
                  (US Dollars in thousands, except for per share data)

                                          Three months ended
                                              December 31,
                                   2009                       2008
                           GAAP     Adj.   NON-GAAP     GAAP   Adj.  NON-GAAP

    Total revenue (1)     9,762       -      9,762    10,404    77    10,481

    Total cost of
    revenue (2)           1,719    (147)     1,572     2,142  (148)    1,994

    Gross profit          8,043     147      8,190     8,262   225     8,487

    Research and
    development expenses,
    net                   1,347       -      1,347     1,657     -     1,657

    Selling, general and
    administrative
    expenses (2)          5,923    (100)     5,823     5,953  (100)    5,853
    Operating income
    (loss)                  773     247      1,020       652   325       977

    Financial income
    (expenses), net.         38       -         38      (207)    -      (207)

    Taxes on Income (3)     639    (726)       (87)      263  (478)     (215)

    Other (4)               (41)     43          2         5     -         5

    Net income (loss)     1,409    (436)       973       713  (153)      560

    Less: Net loss
    (gain) attributable
    to the noncontrolling
    interest                (18)      -        (18)    (*)(7)    -    (*) (7)


    Net income (loss)
    attributable to
    Cimatron's
    shareholders        $ 1,391  $ (436)     $ 955     $ 706 $(153)    $ 553
    Net income per share
    - basic and diluted  $ 0.15             $ 0.10    $ 0.08          $ 0.06

    Weighted average
    number of shares
    outstanding

    Basic EPS
    (in thousands)        9,128              9,128     9,274           9,274

    Diluted EPS
    (in thousands)        9,128              9,128     9,274           9,274





                                         Twelve months ended
                                              December 31,
                                   2009                        2008
                           GAAP     Adj.   NON-GAAP     GAAP    Adj. NON-GAAP

    Total revenue (1)    32,957       -     32,957    40,975    821   41,796

    Total cost of
    revenue (2)           6,186    (588)     5,598     7,769   (588)   7,181

    Gross profit         26,771     588     27,359    33,206  1,409   34,615

    Research and
    development
    expenses, net         5,736       -      5,736     6,930      -    6,930

    Selling, general
    and administrative
    expenses (2)         21,992    (400)    21,592    25,750   (400)  25,350

    Operating income
    (loss)                 (957)    988         31       526  1,809    2,335

    Financial income
    (expenses), net.         19       -         19       (80)     -      (80)

    Taxes on Income (3)     949    (999)       (50)      237   (358)    (121)

    Other (4)               (41)     43          2         -      -        -

    Net income (loss)       (30)     32          2       683  1,451    2,134

    Less: Net loss (gain)
    attributable to the
    noncontrolling interest  44       -         44     (*)41      -    (*)41

    Net income (loss)
    attributable to
    Cimatron's
    shareholders           $ 14    $ 32       $ 46     $ 724 $1,451  $ 2,175

    Net income per share
    - basic and diluted  $ 0.00             $ 0.01    $ 0.08          $ 0.23


    Weighted average
    number of shares
    outstanding

            Basic EPS
           (in thousands) 9,156              9,156     9,341           9,341

            Diluted EPS
           (in thousands) 9,156              9,156     9,360           9,360

    (*) Reclassification due to the adoption of SFAS 160

    (1) Non-GAAP adjustment related to Gibbs' assumed support contracts
        that were not recognized on a GAAP basis in fiscal 2008 or thereafter
        due to business combination accounting rules.
    (2) Non-GAAP adjustment to exclude non-cash amortization of acquired
        intangible assets.
    (3) Non-GAAP adjustment to exclude the effect of deferred taxes.
    (4) Non-GAAP adjustment to exclude loss from discontinued operations.



                           CIMATRON LIMITED
                     CONSOLIDATED BALANCE SHEETS
                      (US Dollars in thousands)

                                                   December 31,  December 31,
                                                          2009          2008

                           ASSETS

    CURRENT ASSETS:
      Total cash, cash equivalents and
      short-term investments                           $ 6,684       $ 5,727
      Trade receivables                                  5,422         7,108
      Other current assets                               3,308         2,697
        Total current assets                            15,414        15,532

        Deposits with insurance companies
        and severance pay fund                           2,935         2,719
        Net property and equipment                       1,046         1,312
        Total other assets                              13,285        14,307
          Total assets                                $ 32,680      $ 33,870

             LIABILITIES AND SHAREHOLDERS' EQUITY

    CURRENT LIABILITIES:
      Short-term bank credit                             $ 456         $ 155
      Trade payables                                     1,064         1,865
      Accrued expenses and other liabilities             6,991         7,348
      Deferred revenues                                  2,397         2,348
        Total current liabilities                       10,908        11,716

    LONG-TERM LIABILITIES:
      Accrued severance pay                              4,104         3,933
      Long-term loan                                       204           293
      Deferred tax liability                             1,365         1,729
      Total long-term liabilities                        5,673         5,955


      Total shareholders' equity                        16,099     (*)16,199

      Total liabilities and shareholders' equity      $ 32,680      $ 33,870

      (*) Reclassification due to the adoption of SFAS 160






                                CIMATRON LIMITED
                  STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

                             (US Dollars in thousands)

                                                                 Accumulated
                                                    Additional         other
                            Non-controlling   Share    paid-in comprehensive
                                   Interest capital    capital income (loss)
    Balance at
    December 31, 2008                 $ (4)   $ 304   $ 18,131          $ 65

    Changes during the
    twelve months ended
    December 31, 2009:

    Net gain (loss)                    (44)

    Unrealized loss on
    derivative instruments                                               (81)

    Stock option
    compensation                                            73

    Investment in treasury
    stock

    Foreign currency
    translation adjustment                                                91

    Total comprehensive loss

    Balance at
    December 31, 2009                $ (48)   $ 304   $ 18,204          $ 75

                             Retained
                             earnings            Comprehensive         Total
                         (accumulated  Treasury         income  shareholders'
                             deficit)     stock          (loss)       equity
    Balance at
    December 31, 2008       $ (1,908)    $ (389)                    $ 16,199

    Changes during the
    twelve months ended
    December 31, 2009:

    Net gain (loss)               14                       (30)          (30)

    Unrealized loss on
    derivative instruments                                 (81)          (81)

    Stock option
    compensation                                                          73

    Investment in
    treasury stock                         (153)                        (153)

    Foreign currency
    translation adjustment                                  91            91

    Total comprehensive
    loss                                                   (20)

    Balance at
    December 31, 2009        $ (1,894)   $ (542)                    $ 16,099





                              CIMATRON LIMITED
                           STATEMENTS OF CASH FLOWS
                           (US Dollars in thousands)

                                                 Twelve months ended
                                                      December 31,
                                               2009                  2008

    Cash flows from operating activities:



    Net (loss) gain                           $ (30)             (*)$ 683

    Adjustments to reconcile net loss
    to net cash provided by operating
    activities:
    Depreciation and amortization             1,575                 1,584
    Increase in accrued severance pay           138                     4
    Gain from sale of property and
    equipment, net                                -                    (3)
    Stock option compensation                    73                   115
    Loss on disposal of businesses -
    discontinued operations                      43                     -
    Deferred taxes, net                        (984)                 (359)

    Changes in assets and liabilities:
    Increase in accounts receivable and
    prepaid expenses                          1,854                 2,475
    Decrease (increase) in inventory            (15)                   26
    Increase in deposits with insurance
    companies and severance pay fund           (216)                  (16)
    Decrease in trade payables, accrued
    expenses and other liabilities           (1,164)               (1,739)
    Net cash provided by operating
    activities                                1,274                 2,770

    Cash flows from investing activities:
    Proceeds from sale of property and
    equipment                                     -                     2
    Proceeds from sale and redemption of bonds    -                 1,245
    Purchase of property and equipment         (262)                 (438)
    Cash and cash equivalents disposed of
    discontinued operations                     (46)                    -
    Additional payment for acquisition of
    subsidiary                                    -                (1,268)
    Acquisition of newly-consolidated
    subsidiaries (Appendix A)                     -                (4,761)
    Net cash used in investing activities      (308)               (5,220)

    Cash flows from financing activities:
    Short-term bank credit                      301                  (637)
    Long-term bank credit                      (104)                    4
    Proceeds from issuance of shares upon
    exercise of options                           -                    14
    Investment in treasury stock               (153)                 (230)
    Net cash provided (used) in financing
    activities                                   44                  (849)

    Net increase (decrease) in cash and cash
    equivalents                               1,010                 (3,299)
    Effect of exchange rate changes on cash     (53)                     -
    Cash and cash equivalents at beginning of
    period                                    5,727                  9,026
    Cash and cash equivalents at end of
    period                                  $ 6,684                $ 5,727

    Appendix A - Acquisition of subsidiary, net of cash acquired
               Working capital - excluding cash                       (879)
               Goodwill                                              4,035
               Other intangible assets                               5,432
               Property and equipment                                  158
               Tax Asset                                               302
                                                                     9,048

               Issuance of shares                                   (4,287)

                                                                   $ 4,761
    Appendix B - Non-cash transactions
               Purchase of property on credit  $ 10                    $ 5

    (*) Reclassification due to the adoption of SFAS 160


    Contact:

    Ilan Erez, Chief Financial Officer
    Cimatron Ltd.
    Tel.; +972-3-531-2121
    E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.